Kyle Schmanke

Experienced Radiation Oncology Consultant: Medical Physics, Medical Devices, Hardware & Software, Patient Safety

[Kyle Schmanke @SafeCancerTx]

“Chloroquine and hydroxychloroquine for cancer therapy” https://t.co/ILgtZ4VV1U

[Kyle Schmanke @SafeCancerTx]

“Masks 101: What you need to know
” https://t.co/Ku3CVvYwfr

[Kyle Schmanke @SafeCancerTx]

Team Crafty & UCSF - Conquering Cancer During Covid-19 https://t.co/K8VNpEVrYm

[Kyle Schmanke @SafeCancerTx]

“Radiotherapy Outcomes Potentially Differ According to Gender” https://t.co/33gWksIYc5

[Kyle Schmanke @SafeCancerTx]

“Clinical development of platinum complexes in cancer therapy: an historical perspective and an update” https://t.co/63cesWE9E5

[Kyle Schmanke @SafeCancerTx]

“Case Study Shows Efficacy from Tocilizumab in Patient With COVID-19, Myeloma” https://t.co/eDhUqj4DG8

[Kyle Schmanke @SafeCancerTx]

“Research Suggests Liver Cancer Prevention Strategy Should Include NASH, Elderly Patients” https://t.co/QexfIlnnaZ

[Kyle Schmanke @SafeCancerTx]

“As families face the uncertainties of a cancer diagnosis and the COVID-19 pandemic, Social Work is putting together WebEx support groups for patients and caregivers.” https://t.co/Ntz9MNLM4F

[Kyle Schmanke @SafeCancerTx]

“New advanced protection for skin care during and after radiotherapy” https://t.co/AWZ4bvheWT

[Kyle Schmanke @SafeCancerTx]

“FDA Approves Luspatercept to Treat Anemia in Patients with Lower-Risk MDS” https://t.co/fzs6vRIQoh

[Kyle Schmanke @SafeCancerTx]

“COVID-19 May Be Less Severe in Pediatric Patients” https://t.co/PnIn4Anate

[Kyle Schmanke @SafeCancerTx]

Some Coronavirus Patients Show Signs of Brain Ailments https://t.co/lQA8wUEcwq

[Kyle Schmanke @SafeCancerTx]

“Paul McCartney inducts John Lennon into the Rock and Roll Hall of Fame” https://t.co/mnnnvR6KF4

[Kyle Schmanke @SafeCancerTx]

“Natural Killer Cell Therapies Catch Up to CAR T” https://t.co/qzedfANbnQ

[Kyle Schmanke @SafeCancerTx]

“Improved Long-Term QOL Observed for Pediatric Cancer Survivors as Treatments Evolve” https://t.co/AyxhopmTQO

[Kyle Schmanke @SafeCancerTx]

“Changes in Surface Sugarlike Molecules Help Cancer Metastasize” https://t.co/qK89q2gvuL

[Kyle Schmanke @SafeCancerTx]

“Differentiation & Risk Stratification of Pancreatic Cysts” https://t.co/BelKmtGYwW

[Kyle Schmanke @SafeCancerTx]

“Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study” https://t.co/jjQH961dsA

[Kyle Schmanke @SafeCancerTx]

“ Protecting Cancer Patients During the Coronavirus Pandemic” https://t.co/apB9DhkoYh

[Kyle Schmanke @SafeCancerTx]

“San Antonio Breast Cancer Symposium: New Therapies for Women With HER2-Positive Breast Cancer Highlighted on Day 1” https://t.co/13tukxm0l2